ATE416768T1 - Querverweise von tetrahydrothiopyrano-pyrazol- cannabinoidmodulatoren zu verwandten anmeldungen - Google Patents
Querverweise von tetrahydrothiopyrano-pyrazol- cannabinoidmodulatoren zu verwandten anmeldungenInfo
- Publication number
- ATE416768T1 ATE416768T1 AT06738484T AT06738484T ATE416768T1 AT E416768 T1 ATE416768 T1 AT E416768T1 AT 06738484 T AT06738484 T AT 06738484T AT 06738484 T AT06738484 T AT 06738484T AT E416768 T1 ATE416768 T1 AT E416768T1
- Authority
- AT
- Austria
- Prior art keywords
- tetrahydrothiopyrano
- related applications
- cross references
- cannabinoid modulators
- pyrazole cannabinoid
- Prior art date
Links
- UBEXPFAJZMPWAL-UHFFFAOYSA-N 1,2,3,3a-tetrahydrothiopyrano[3,2-c]pyrazole Chemical compound C1=CSC2CNNC2=C1 UBEXPFAJZMPWAL-UHFFFAOYSA-N 0.000 title 1
- 229930003827 cannabinoid Natural products 0.000 title 1
- 239000003557 cannabinoid Substances 0.000 title 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000035475 disorder Diseases 0.000 abstract 1
- 230000001404 mediated effect Effects 0.000 abstract 1
- 102000005962 receptors Human genes 0.000 abstract 1
- 108020003175 receptors Proteins 0.000 abstract 1
- 208000011580 syndromic disease Diseases 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
- A61K31/4162—1,2-Diazoles condensed with heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Neurology (AREA)
- Diabetes (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Pain & Pain Management (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Ophthalmology & Optometry (AREA)
- Psychiatry (AREA)
- Physical Education & Sports Medicine (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Addiction (AREA)
- Pulmonology (AREA)
- Child & Adolescent Psychology (AREA)
- Rheumatology (AREA)
- Emergency Medicine (AREA)
- Hospice & Palliative Care (AREA)
- Endocrinology (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US66689805P | 2005-03-31 | 2005-03-31 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE416768T1 true ATE416768T1 (de) | 2008-12-15 |
Family
ID=36587178
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT06738484T ATE416768T1 (de) | 2005-03-31 | 2006-03-16 | Querverweise von tetrahydrothiopyrano-pyrazol- cannabinoidmodulatoren zu verwandten anmeldungen |
Country Status (18)
| Country | Link |
|---|---|
| US (2) | US20060223798A1 (enExample) |
| EP (1) | EP1863479B1 (enExample) |
| JP (1) | JP5127697B2 (enExample) |
| KR (1) | KR20080004559A (enExample) |
| CN (1) | CN101189007A (enExample) |
| AT (1) | ATE416768T1 (enExample) |
| AU (1) | AU2006232945B2 (enExample) |
| BR (1) | BRPI0609790A2 (enExample) |
| CA (1) | CA2603104A1 (enExample) |
| CO (1) | CO6321135A2 (enExample) |
| CR (1) | CR9479A (enExample) |
| DE (1) | DE602006004197D1 (enExample) |
| EA (1) | EA200702130A1 (enExample) |
| IL (1) | IL186430A0 (enExample) |
| MX (1) | MX2007012233A (enExample) |
| NO (1) | NO20075463L (enExample) |
| WO (1) | WO2006107561A1 (enExample) |
| ZA (1) | ZA200709342B (enExample) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101863903B (zh) * | 2010-06-08 | 2014-03-12 | 沈阳药科大学 | 1,4-二氢噻吩并[3’,2’:5,6]噻喃并[4,3-c]吡唑-3-羧酸衍生物及其应用 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2800375B1 (fr) * | 1999-11-03 | 2004-07-23 | Sanofi Synthelabo | Derives tricycliques d'acide pyrazolecarboxylique, leur preparation, les compositions pharmaceutiques en contenant |
| JP2004502642A (ja) * | 2000-02-11 | 2004-01-29 | ブリストル−マイヤーズ スクイブ カンパニー | カンナビノイドレセプターモジュレーター、それらの製造方法、および呼吸系および非呼吸系疾患の処置のためのカンナビノイドレセプターモジュレーターの使用 |
| WO2003035005A2 (en) * | 2001-10-26 | 2003-05-01 | University Of Connecticut | Heteroindanes: a new class of potent cannabimimetic ligands |
| US20040214856A1 (en) * | 2003-04-23 | 2004-10-28 | Pfizer Inc | Cannabinoid receptor ligands and uses thereof |
| US7145012B2 (en) * | 2003-04-23 | 2006-12-05 | Pfizer Inc. | Cannabinoid receptor ligands and uses thereof |
-
2006
- 2006-03-16 BR BRPI0609790-1A patent/BRPI0609790A2/pt not_active IP Right Cessation
- 2006-03-16 WO PCT/US2006/009424 patent/WO2006107561A1/en not_active Ceased
- 2006-03-16 CA CA002603104A patent/CA2603104A1/en not_active Abandoned
- 2006-03-16 KR KR1020077025259A patent/KR20080004559A/ko not_active Withdrawn
- 2006-03-16 EP EP06738484A patent/EP1863479B1/en not_active Expired - Lifetime
- 2006-03-16 US US11/376,844 patent/US20060223798A1/en not_active Abandoned
- 2006-03-16 MX MX2007012233A patent/MX2007012233A/es active IP Right Grant
- 2006-03-16 JP JP2008504108A patent/JP5127697B2/ja not_active Expired - Fee Related
- 2006-03-16 EA EA200702130A patent/EA200702130A1/ru unknown
- 2006-03-16 AT AT06738484T patent/ATE416768T1/de not_active IP Right Cessation
- 2006-03-16 DE DE602006004197T patent/DE602006004197D1/de not_active Expired - Lifetime
- 2006-03-16 CN CNA2006800192594A patent/CN101189007A/zh active Pending
- 2006-03-16 AU AU2006232945A patent/AU2006232945B2/en not_active Ceased
-
2007
- 2007-10-07 IL IL186430A patent/IL186430A0/en unknown
- 2007-10-17 CO CO07109275A patent/CO6321135A2/es not_active Application Discontinuation
- 2007-10-29 NO NO20075463A patent/NO20075463L/no not_active Application Discontinuation
- 2007-10-29 CR CR9479A patent/CR9479A/es not_active Application Discontinuation
- 2007-10-30 ZA ZA200709342A patent/ZA200709342B/xx unknown
- 2007-12-07 US US11/952,375 patent/US7524964B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| US7524964B2 (en) | 2009-04-28 |
| BRPI0609790A2 (pt) | 2010-04-27 |
| WO2006107561A1 (en) | 2006-10-12 |
| KR20080004559A (ko) | 2008-01-09 |
| AU2006232945A1 (en) | 2006-10-12 |
| AU2006232945B2 (en) | 2012-02-23 |
| JP2008535829A (ja) | 2008-09-04 |
| MX2007012233A (es) | 2008-03-18 |
| EP1863479B1 (en) | 2008-12-10 |
| CA2603104A1 (en) | 2006-10-12 |
| US20060223798A1 (en) | 2006-10-05 |
| CO6321135A2 (es) | 2011-09-20 |
| DE602006004197D1 (de) | 2009-01-22 |
| EA200702130A1 (ru) | 2008-04-28 |
| EP1863479A1 (en) | 2007-12-12 |
| CR9479A (es) | 2008-09-09 |
| US20080085899A1 (en) | 2008-04-10 |
| IL186430A0 (en) | 2008-01-20 |
| ZA200709342B (en) | 2009-09-30 |
| NO20075463L (no) | 2007-12-21 |
| CN101189007A (zh) | 2008-05-28 |
| JP5127697B2 (ja) | 2013-01-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TW200602324A (en) | Tetrahydro-indazole cannabinoid modulators cross reference to related applications | |
| IL190348A0 (en) | Hexahydro cyclooctyl pyrazole cannabinoid modulators | |
| EA200900828A1 (ru) | Соединения и композиции в качестве ингибиторов активности каннабиноидного рецептора 1 | |
| DK2049475T3 (da) | Cyclohexyl-substituerede pyrrolidinoner som inhibitorer af 11-beta-hydroxysteroid dehydrogenase1 | |
| DK2029529T3 (da) | Substitueret pyrrolidinone som inhibitor af 11-beta-hydroxysteroiddehydrogenase 1 | |
| BRPI0513677B8 (pt) | derivados de pirrol como agentes farmacêuticos | |
| ATE484505T1 (de) | 5-sulfanylmethylä1,2,4ütriazolä1,5-aüpyrimidin- - olderivate als cxcr2-antagonisten | |
| NO20082505L (no) | Substtuert 5-heteroaryl-1-fenyl-pyrazol-cannabinoid-modulatorer | |
| BRPI0517378A (pt) | moduladores de tetraidro piridinil pirazol canabinóide | |
| MX2010001714A (es) | Moduladores de canabinoides 5-vinilfenil-1-fenil-pirazol sustituidos. | |
| UA98487C2 (en) | Hexahydro-cycloheptapyrazole cannabinoid modulators | |
| BRPI0409580A (pt) | compostos de quinazolina | |
| TW200733961A (en) | Diaryl urea for treating pulmonary hypertension | |
| ZA200803532B (en) | Hexahydro-cycloheptapyrazole cannabinoid modulators | |
| EA200600590A1 (ru) | Фармацевтические композиции модафинила с модифицированным высвобождением | |
| DE602006004197D1 (de) | Querverweise von tetrahydrothiopyrano-pyrazol-cannabinoidmodulatoren zu verwandten anmeldungen | |
| ATE538122T1 (de) | Acetamid- und carboxamid-derivate von azaadamantan sowie verfahren zu ihrer verwendung | |
| MX2009010159A (es) | Moduladores de cannabinoides hexahidro-ciclooctil pirazol. | |
| DK1377294T3 (da) | Anvendelse af neuroaktive stoffer til behandling af Parkinson's sygdom og farmaceutisk kombination | |
| WO2005041875A3 (en) | Dopamine-, norepinephrine- and serotonin- transporter- selective heterocyclic compounds and their therapeutic applications |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |